Ratiopharm
From Wikipedia, the free encyclopedia
 |
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (March 2010) |
| Type | Private |
|---|---|
| Industry | Pharmaceutical industry |
| Founded | 1974 |
| Headquarters | Ulm, Germany |
| Key people | Adolf Merckle, founder Oliver Windholz, CEO |
| Products | Pharmaceuticals and generic medication. |
| Revenue |  € 1.8 billion (2007) |
| Employees | 5,417 (2007) |
| Website | Ratiopharm.com |
Ratiopharm is a German pharmaceutical company that is Europe's leading generics brand.
Ratiopharm was owned by Adolf Merckle and makes generic Pharmaceuticals. They are based in Ulm, Germany and products being distributed in over 35 countries worldwide.
On March 18, 2010, Teva announced that it planned to acquire Ratiopharm for US$5 billion.[1][2] On August 10, 2010, Teva announced that it had completed its acquisition of Ratiopharm.[3]
[edit] See also
[edit] References
- ^ NATASHA SINGER (March 18, 2010). "Teva to Acquire Top German Generics Maker for $5 Billion". The New York Times. http://www.nytimes.com/2010/03/19/business/global/19drugs.html. Retrieved March 18, 2010.
- ^ Teva to Acquire Generics Firm The Wall Street Journal March 19, 2010
- ^ "Teva Completes Acquisition of Ratiopharm". August 10, 2010. http://www.tevapharm.com/pr/2010/pr_954.asp. Retrieved August 20, 2010.
[edit] External links
 |
This German corporation or company article is a stub. You can help Wikipedia by expanding it. |
